04750nam a2200733 i 450099100349127970753620021217151609.0961025m19741983us a 000 0 eng db11818906-39ule_instLE00301671ExLDip.to Biologiaeng572.722Hormone action /edited by Jackie D. Corbin, Joel G. HardmanNew York :Academic Press,[1975-1989]11 v. :ill. ;24 cmMethods in enzymology ;036Methods in enzymology ;037Methods in enzymology ;038Methods in enzymology ;039Methods in enzymology ;040Methods in enzymology ;099Methods in enzymology ;102Methods in enzymology ;103Methods in enzymology ;109Methods in enzymology ;124Methods in enzymology ;168Includes bibliographies and indexesIn pts. C and D Hardman's name is firstPt. A:Steroid hormones /edited by Bert W. O'Malley, Joel G. Hardman. - 1975. - xviii, 575 p. : ill. Pt. B:Peptide hormones /edited by Bert W. O'Malley, Joel G. Hardman. - 1975. - xvi, 463 p. : ill.Pt. C:Cyclic nucleotides /edited by Joel G. Hardman, Bert W. O'Malley. - 1974. - xxi, 454 p. : ill.Pt. D:Isolated cells, tissues, and organ systems /edited by Joel G. Hardman, Bert W. O'Malley. - 1975. - xviii, 608 p. : ill.Pt. E:Nuclear structure and function /edited by Bert W. O'Malley, Joel G. Hardman. - 1975. - xiv, 404 p. : ill. Pt. F:Proteins kinases /edited by Jackie D. Corbin, Joel G. Hardman. - 1983. - xxiv, 433 p.Pt. G:Calmodulin and calcium-binding proteins /edited by Anthony R. Means, Bert W. O'Malley. - 1983. - xxiv, 336 p.Pt. H: Neuroendocrine peptides /edited by P. Michael Conn. - 1983. - xxvi, 740 p.Pt. I:Peptide hormones /edited by Lutz Birnbaumer, Bert W. O'Malley. - 1985. - xxviii, 891 p.Pt. J-K:Neuroendocrine peptides /edited by P. Michael Conn. - c1986-c1989. - 2 v. : ill.Cell nucleusCyclic nucleotidesEnzymesHormonesHardman, Joel G.Means, Anthony R.O'Malley, Bert W.Corbin, Jackie D..b1181890627-04-1718-12-02991003491279707536LE002 Coll. 21.036 [dislocato c/o Biblioteca DiSTeBA]Pt. A12002000001702le003-E0.00-l- 00000.i1052165327-06-02LE002 Coll. 21.037 [dislocato c/o Biblioteca DiSTeBA]Pt. B12002000001719le003-E0.00-l- 00000.i1052166527-06-02LE002 Coll. 21.038 [dislocato c/o Biblioteca DiSTeBA]Pt. C12002000001726le003-E0.00-l- 00000.i1052167727-06-02LE002 Coll. 21.039 [dislocato c/o Biblioteca DiSTeBA]Pt. D12002000001733le003-E0.00-l- 00000.i1052168927-06-02LE002 Coll. 21.040 [dislocato c/o Biblioteca DiSTeBA]Pt. E12002000266552 le003-E0.00-l- 00000.i1325104105-04-04LE003 572.7 MET01.01 099 (1983)Pt. F12003000008012le003-E0.00-l- 00000.i1206940118-12-02LE002 Coll. 21.099 [dislocato c/o Biblioteca DiSTeBA]Pt. F22002000001740le003-E0.00-l- 00000.i1052169027-06-02LE003 572.7 MET01.01 102 (1983)Pt. G12003000008159le003-E0.00-l- 00000.i1206941318-12-02LE002 Coll. 21.102 [dislocato c/o Biblioteca DiSTeBA]Pt. G22002000001757le003-E0.00-l- 00000.i1052170727-06-02LE002 Coll. 21.103 [dislocato c/o Biblioteca DiSTeBA]Pt. H12002000001764le003-E0.00-l- 00000.i1052171927-06-02LE002 Coll. 21.109 [dislocato c/o Biblioteca DiSTeBA]Pt. I12002000001771le003-E0.00-l- 00000.i1052172027-06-02LE002 Coll. 21.124 [dislocato c/o Biblioteca DiSTeBA]Pt. J12002000001788le003-E0.00-l- 00000.i1052173227-06-02LE002 Coll. 21.168 [dislocato c/o Biblioteca DiSTeBA]Pt. K12002000001795le003-E0.00-l- 00000.i1052174427-06-02Hormone action84859UNISALENTOle00301-01-96ma -engus 0201498nam0 2200349 i 450 CFI020084020231121125446.0881316802020150824d1989 ||||0itac50 baitaitz01i xxxe z01n˜Il œconsigliere comunaleGianfranco Bettin, Annick MagnierPadovaCEDAM1989XI, 305 p.22 cm.Biblioteca di sociologia3001CFI00782732001 Biblioteca di sociologia3SociologiaFIRRMLC002505EBettin Lattes, GianfrancoRMGV007929070468086Magnier, AnnickCFIV081615070148033Bettin, Gianfranco <1940- >CFIV180349Bettin Lattes, GianfrancoITIT-0120150824IT-FR0017 IT-FR0098 Biblioteca umanistica Giorgio ApreaFR0017 Biblioteca Area Giuridico EconomicaFR0098 CFI0200840Biblioteca umanistica Giorgio Aprea 52CIS 14/371 52VM 0000217565 VM barcode:00079445. - Inventario:634 FSSVMA 2010090920121204Biblioteca Area Giuridico Economica 53DSG 06/0162 53VM 0000217555 VM barcode:GIU0002953. - Inventario:2018VMA 2001042320121204 52 53Consigliere comunale889612UNICAS04882nam 22007335 450 991040968990332120250609110101.03-030-43032-410.1007/978-3-030-43032-0(CKB)4100000011279310(MiAaPQ)EBC6216615(DE-He213)978-3-030-43032-0(PPN)248595636(MiAaPQ)EBC6216544(EXLCZ)99410000001127931020200601d2020 u| 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierCurrent Advances in Osteosarcoma Clinical Perspectives: Past, Present and Future /edited by Eugenie S. Kleinerman, Richard Gorlick2nd ed. 2020.Cham :Springer International Publishing :Imprint: Springer,2020.1 online resource (212 pages)Advances in Experimental Medicine and Biology,2214-8019 ;12573-030-43034-0 3-030-43031-6 Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective -- Part 1: Surgical Considerations and Outcomes -- Limb Salvage and Reconstruction Options in Osteosarcoma -- Advances in the functional assessment of patients with sarcoma -- Part II: Novel Therapeutic Approaches Based on Biology -- Radiopharmaceuticals for Treatment of Osteosarcoma -- HER-2 Targeted Therapy in Osteosarcoma -- Aerosolized Chemotherapy for Osteosarcoma -- The Histone Deacetylase inhibitor Entinostat/Syndax 275 in Osteosarcoma -- Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the Disease -- Using liquid biopsy in the treatment of patient with osteosarcoma -- Part III: Novel Immunotherapeutic Approaches -- Genetically modified T-cell therapy for osteosarcoma: into the roaring 2020’s -- Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma -- Natural Killer Cell Immunotherapy for Osteosarcoma -- Nanocapsule delivery of IL-12 -- Discovery of cell surface vimentin (CSV) as a sarcoma target and development of CSV-targeted IL-12 immune therapy -- Part IV: Survivorship and Late Effects -- Editorial Comments on late effects -- Anthracycline-Induced Cardiotoxicity: Causes, mechanisms & prevention -- Exercise and Physical Activity in Patients with Osteosarcoma and Survivors -- Index.This thoroughly revised second edition complied in 2 books is an up-to-date overview of the current clinical advances in sarcoma and osteosarcoma. The new edition features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, these essential volumes also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes, Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, are a timely and urgently needed guide for laboratory investigators and clinical oncologists focused in sarcoma.Advances in Experimental Medicine and Biology,2214-8019 ;1257CancerMedical microbiologyCytologyPediatricsCancer BiologyMedical MicrobiologyCell BiologyPediatricsOsteosarcomathubSarcomathubTerapèuticathubLlibres electrònicsthubCancer.Medical microbiology.Cytology.Pediatrics.Cancer Biology.Medical Microbiology.Cell Biology.Pediatrics.OsteosarcomaSarcomaTerapèutica616.99471Kleinerman Eugenie Sedthttp://id.loc.gov/vocabulary/relators/edtGorlick Richardedthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910409689903321Current Advances in Osteosarcoma2139472UNINA